BMI Korea

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

BMI2006 · Diabetes
BMI2006 is a small molecule drug that targets the SGLT2 receptor.

Phase 1 pipeline

BMI2004

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

BMI Korea portfolio CI brief
BMI Korea pipeline updates RSS

Frequently asked questions about BMI Korea

What is BMI Korea's pipeline?

BMI Korea has 1 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include BMI2006.

Sector hub: All tracked pharma companies